89bio Inc (NASDAQ: ETNB) open the trading on Wednesday, with great promise as it jumped 2.70% to $9.14, before settling in for the price of $8.90 at the close. Taking a more long-term approach, ETNB posted a 52-week range of $7.00-$16.63.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 0.00% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -11.24%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -58.84%. This publicly-traded company’s shares outstanding now amounts to $117.58 million, simultaneously with a float of $112.43 million. The organization now has a market capitalization sitting at $1.07 billion. At the time of writing, stock’s 50-day Moving Average stood at $8.22, while the 200-day Moving Average is $9.07.
89bio Inc (ETNB) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. 89bio Inc’s current insider ownership accounts for 4.38%, in contrast to 89.21% institutional ownership. According to the most recent insider trade that took place on Nov 22 ’24, this organization’s Chief Executive Officer bought 10,000 shares at the rate of 8.35, making the entire transaction reach 83,500 in total value, affecting insider ownership by 466,236. Preceding that transaction, on Oct 30 ’24, Company’s insider sold 27,955 for 8.12, making the whole transaction’s value amount to 226,995. This particular insider is now the holder of 187,796 in total.
89bio Inc (ETNB) Earnings and Revenue Records
89bio Inc’s EPS decrease for this current 12-month fiscal period is -58.84% and is forecasted to reach -2.93 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 11.00% through the next 5 years, which can be compared against the -11.24% growth it accomplished over the previous five years trading on the market.
89bio Inc (NASDAQ: ETNB) Trading Performance Indicators
Let’s observe the current performance indicators for 89bio Inc (ETNB). It’s Quick Ratio in the last reported quarter now stands at 11.65. The Stock has managed to achieve an average true range (ATR) of 0.61.
In the same vein, ETNB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.91, a figure that is expected to reach -0.75 in the next quarter, and analysts are predicting that it will be -2.93 at the market close of one year from today.
Technical Analysis of 89bio Inc (ETNB)
[89bio Inc, ETNB] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 67.48% While, its Average True Range was 0.62.
Raw Stochastic average of 89bio Inc (ETNB) in the period of the previous 100 days is set at 57.53%, which indicates a major rise in contrast to 48.11% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 73.63% that was higher than 62.96% volatility it exhibited in the past 100-days period.
